A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range

NCT06041217 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

242

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DRUG: Semaglutide
DRUG: Placebo

Sponsor

Novo Nordisk A/S